COVID-19 presentations and outcome in patients with epilepsy
The European Parliament marked Brain Health Day: Prevention, Policy, Progress with a high‑level programme hosted by MEP Angelika Winzig, bringing renewed political attention to Europe’s urgent need for an integrated brain health strategy.
Latest Posts
-
-
Breaking newsCOVID-19ResearchNeurobiology of SARS-CoV-2 interactions with the peripheral nervous system: implications for COVID-19 and pain
Neurobiology of SARS-CoV-2 interactions with the peripheral nervous system: implications for COVID-19 and pain -
Breaking newsCOVID-19ResearchSusceptibility-weighted imaging reveals cerebral microvascular injury in severe COVID-19
Susceptibility-weighted imaging reveals cerebral microvascular injury in severe COVID-19 -
Breaking newsCOVID-19Research
COVID 19-induced smell and taste impairments: Putative impact on physiology
COVID 19-induced smell and taste impairments: Putative impact on physiology -
Breaking newsCOVID-19Research
COVID-19 Pathophysiology predicts that ischaemic stroke occurrence is an expectation, not an exception—A systematic review
COVID-19 Pathophysiology predicts that ischaemic stroke occurrence is an expectation, not an exception—A systematic review -
Breaking newsCOVID-19Research
Infection mechanism of SARS-COV-2 and its implication on the nervous system
Infection mechanism of SARS-COV-2 and its implication on the nervous system -
Breaking newsCOVID-19ResearchCognitive decline among individuals with history of mild symptomatic SARS‐CoV‐2 infection. A longitudinal prospective study nested to a population cohort.
Cognitive decline among individuals with history of mild symptomatic SARS‐CoV‐2 infection. A longitudinal prospective study nested to a population cohort. -
Breaking newsCOVID-19Research
Acute‐onset delirium in intensive care COVID patients: association of imperfect brain repair with foodborne micro‐pollutants
Acute‐onset delirium in intensive care COVID patients: association of imperfect brain repair with foodborne micro‐pollutants -
Breaking newsCOVID-19Research
Disease‐modifying therapies and coronavirus disease 2019 severity in multiple sclerosis
Disease‐modifying therapies and coronavirus disease 2019 severity in multiple sclerosis -
Breaking newsCOVID-19Research
Incidence and impact of COVID-19 in MS. A survey from a Barcelona MS unit
Incidence and impact of COVID-19 in MS. A survey from a Barcelona MS unit -
Breaking newsCOVID-19Research
Presence of SARS-CoV-2 transcripts in the choroid plexus of MS and non-MS patients with COVID-19
Presence of SARS-CoV-2 transcripts in the choroid plexus of MS and non-MS patients with COVID-19 -
COVID-19 and the human innate immune system
-
Breaking newsCOVID-19Research
Neurotropic effects of SARS-CoV-2 modeled by the human brain organoids
Neurotropic effects of SARS-CoV-2 modeled by the human brain organoids -
Breaking newsCOVID-19ResearchHuman neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection -
Breaking newsCOVID-19Research
Revealing tissue-specific SARS-CoV-2 infection and host responses using human stem cell derived lung and cerebral organoids
Revealing tissue-specific SARS-CoV-2 infection and host responses using human stem cell derived lung and cerebral organoids